Nuwellis, Inc. (NUWE) Q1 2026 Earnings Call Transcript
Nuwellis Q1 2026 Earnings Call Transcript
Nuwellis Q1 EPS $(2.09) Misses $(1.00) Estimate, Sales $2.403M Beat $2.094M Estimate
Nuwellis Highlights Case Study Presented By University Of Iowa Stead Family Children's Hospital The International Society For Heart And Lung Transplantation Meeting
Nuwellis Issued U.S. Patent And Trademark Office Notice Of Allowance For New Patent For Its Novel Dual Lumen Midline Catheter Technology
Nuwellis Announces Formation of South Texas Commercial Territory to Strengthen Field Engagement in Key U.S. Hospital Markets
Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone
Nuwellis Reports ~50% Of U.S. Revenue In 2025
Nuwellis Completes Acquisition of Rendiatech
Nuwellis, Inc. Q4 2025 Earnings Call Summary
Nuwellis (NUWE) Q4 2025 Earnings Call Transcript
Nuwellis Inc (NASDAQ:NUWE) Stock Surges 10% on Q4 Earnings Beat
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
Nuwellis Q4 EPS $(1.50) Beats $(1.56) Estimate, Sales $2.424M Beat $2.310M Estimate
Nuwellis Earnings Preview
Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy
Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors
Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
Benzinga Bulls And Bears: Microsoft, Meta, UnitedHealth — And Warsh Pick Jolts Markets
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.